Form 4 for PFE Pfizer
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003667 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-26 | PFE | LANKLER DOUGLAS M | EVP | M - OptEx | $25.60 | +77.7K | 174.5K | +80% | +$1.99M |
| DM | 2022-03-01 | 2022-02-26 | PFE | LANKLER DOUGLAS M | EVP | F - Tax | $49.56 | -57.4K | 117.1K | -33% | -$2.85M |
| DM | 2022-03-01 | 2022-02-28 | PFE | LANKLER DOUGLAS M | EVP | A - Grant | $0.00 | +19.9K | 10.6K | New | $0 |
| D | 2022-03-01 | 2022-02-26 | PFE | LANKLER DOUGLAS M | EVP | M - OptEx | $0.00 | -77.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-26 | M | A | 77,709 | $25.60 | 174,507 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2022-02-26 | F | D | 21,149 | $47.72 | 153,358 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022. |
| 3 | Common | Common Stock | 2022-02-26 | F | D | 36,282 | $50.64 | 117,076 | D | — | — | (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 4 | Derivative | Stock Appreciation Rights | 2022-02-28 | A | A | 9,294 | $0.00 | 9,294 | D | $46.94 · 2029-02-28 to 2029-02-28 | 9,294 Common Stock | (F7) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |
| 5 | Derivative | Stock Appreciation Rights | 2022-02-28 | A | A | 10,566 | $0.00 | 10,566 | D | $46.94 · 2027-02-28 to 2027-02-28 | 10,566 Common Stock | (F6) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
| 6 | Derivative | Stock Appreciation Rights | 2022-02-26 | M | D | 77,709 | $0.00 | 0 | D | $25.60 · 2022-02-26 to 2022-02-26 | 77,709 Common Stock |